Product Information

MEMANTINE HCL ER 21 MG CAPSULE is a generic product labeled by Vitruvias Therapeutics Inc., priced at $0.3537 per EA under NDC 69680016330. Its NADAC has been published 88 times since Mar 12, 2025.

FDA first approved this application on Oct 11, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

MEMANTINE HCL ER 21 MG CAPSULE

memantine hydrochloride
$0.3537per EA

Strength

21 mg/1

NDC

69680016330

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

MEMANTINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA213985

FDA Approved

10/11/2022

TE Code

AB

On Market Since

2/19/2024

Pharmacological Classes

Price Statistics

The NADAC for MEMANTINE HCL ER 21 MG CAPSULE has been published 88 times since Mar 12, 2025, and over the history we have for it it has declined 22.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3537 per EA
All-time high$0.4738 (Apr 16, 2025)
All-time low$0.3021 (Dec 17, 2025)
52-week high$0.3585
52-week low$0.3021
Median price$0.3514
Average price$0.3650
Largest weekly change+9.8% (Sep 23, 2026)
Weeks tracked88
Tracking sinceMar 12, 2025

Price History

1W

0.0%

1M

-0.7%

3M

+13.7%

6M

-1.3%

1Y

+1.5%

3Y

N/A

5Y

N/A

All

-22.7%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of MEMANTINE HCL ER 21 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for MEMANTINE HCL ER 21 MG CAPSULE, manufactured by Vitruvias Therapeutics Inc., is $0.3537 per EA (NDC 69680016330), effective Nov 11, 2026.

How has the price of MEMANTINE HCL ER 21 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for MEMANTINE HCL ER 21 MG CAPSULE has declined 22.7%. It has been tracked across 88 weekly CMS publications since Mar 12, 2025.

What are the highest and lowest recorded NADAC prices for MEMANTINE HCL ER 21 MG CAPSULE?

Since Mar 12, 2025, the NADAC for MEMANTINE HCL ER 21 MG CAPSULE has ranged from a low of $0.3021 (Dec 17, 2025) to a high of $0.4738 (Apr 16, 2025), with a median of $0.3514 per EA.

Are there cheaper alternatives to MEMANTINE HCL ER 21 MG CAPSULE?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MEMANTINE HCL ER 21 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures MEMANTINE HCL ER 21 MG CAPSULE?

MEMANTINE HCL ER 21 MG CAPSULE (NDC 69680016330) is labeled by Vitruvias Therapeutics Inc., and CMS classifies it as a generic product.